Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Wei

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Nature Communications|April 2, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)Li-Chung Tsao, John S Wang, Xingru Ma, et al.
JCI Insight|November 6, 2019
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosisLi-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Phenomics (Cham, Switzerland)|August 17, 2023
Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy AdultsZhenghu Jia, Zhiyao Ren, Dongmei Ye, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Science Immunology|December 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunityBin-Jin Hwang, Erika J Crosby, David T Severson, et al.
Journal for Immunotherapy of Cancer|May 7, 2021
Progesterone promotes immunomodulation and tumor development in the murine mammary glandLauryn R Werner, Katelin A Gibson, Merit L Goodman, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Nature Communications|April 2, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)Li-Chung Tsao, John S Wang, Xingru Ma, et al.
JCI Insight|November 6, 2019
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosisLi-Chung Tsao, Erika J Crosby, Timothy N Trotter, et al.
Phenomics (Cham, Switzerland)|August 17, 2023
Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy AdultsZhenghu Jia, Zhiyao Ren, Dongmei Ye, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Science Immunology|December 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunityBin-Jin Hwang, Erika J Crosby, David T Severson, et al.
Journal for Immunotherapy of Cancer|May 7, 2021
Progesterone promotes immunomodulation and tumor development in the murine mammary glandLauryn R Werner, Katelin A Gibson, Merit L Goodman, et al.
Pageof 8